IperionX Limited
IperionX Limited (IPX.AX) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for IperionX Limited (IPX.AX), featuring income statements, balance sheets, and cash flow data.
IperionX Limited (IPX.AX) Income Statement & Financial Overview
Access detailed annual and quarterly income data for IperionX Limited IPX.AX financial performance.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| R&D Expenses | $2475.00 | $2475.00 | $1882.00 | $1882.00 |
| SG&A Expenses | $3774.00 | $3774.00 | $3178.00 | $3178.00 |
| Operating Expenses | $6248.00 | $6248.00 | $5322.00 | $5322.00 |
| Total Costs & Expenses | $6248.00 | $6248.00 | $5322.00 | $5322.00 |
| Interest Income | $0.00 | $0.00 | $74.00 | $74.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $31.00 | $44.00 | $44.00 | $44.00 |
| EBITDA | -$6217.00 | -$6204.00 | -$5016.00 | -$5016.00 |
| EBITDA Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | -$6248.00 | -$6248.00 | -$5060.00 | -$5060.00 |
| Operating Income Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| Other Income/Expenses (Net) | $574.00 | $574.00 | -$187.00 | -$187.00 |
| Income Before Tax | -$5674.00 | -$5674.00 | -$5248.00 | -$5248.00 |
| Income Before Tax Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | -$43232.00 |
| Net Income | -$5674.00 | -$5674.00 | -$5248.00 | -$5248.00 |
| Net Income Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| EPS | $0.00 | $0.00 | $0.00 | $0.00 |
| Diluted EPS | $0.00 | $0.00 | $0.00 | $0.00 |
| Weighted Avg Shares Outstanding | $225.79M | $213.87M | $209.90M | $209.90M |
| Weighted Avg Shares Outstanding (Diluted) | $225.78M | $213.87M | $209.90M | $209.90M |
Financial performance has remained strong, with revenue growing from $0.00 in Q1 2024 to $0.00 in Q4 2024. Gross profit continued to perform well, with margins at N/A in the latest quarter. Operating income reached -$6248.00 in Q4 2024, holding a steady N/A margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at -$6217.00. Net income rose to -$5674.00, keeping EPS at $0.00. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan